Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Germinal Center | 1 | 2023 | 37 | 0.860 |
Why?
|
| Immunity, Humoral | 1 | 2023 | 69 | 0.820 |
Why?
|
| Autoantibodies | 2 | 2016 | 422 | 0.780 |
Why?
|
| Scleroderma, Systemic | 1 | 2016 | 117 | 0.490 |
Why?
|
| Reticulin | 1 | 2013 | 8 | 0.430 |
Why?
|
| Laboratories | 3 | 2023 | 83 | 0.430 |
Why?
|
| Celiac Disease | 1 | 2013 | 69 | 0.400 |
Why?
|
| Clonal Anergy | 3 | 2016 | 5 | 0.300 |
Why?
|
| Mass Screening | 1 | 2013 | 786 | 0.280 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2006 | 44 | 0.270 |
Why?
|
| CREB-Binding Protein | 1 | 2006 | 63 | 0.270 |
Why?
|
| CD28 Antigens | 1 | 2006 | 78 | 0.260 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2016 | 216 | 0.260 |
Why?
|
| Lymphocyte Activation | 2 | 2023 | 678 | 0.240 |
Why?
|
| Transcriptional Activation | 1 | 2006 | 481 | 0.230 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2023 | 77 | 0.210 |
Why?
|
| Certification | 1 | 2023 | 68 | 0.210 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2022 | 65 | 0.190 |
Why?
|
| Allergy and Immunology | 1 | 2021 | 24 | 0.180 |
Why?
|
| B-Lymphocytes | 1 | 2023 | 518 | 0.170 |
Why?
|
| Societies, Medical | 1 | 2021 | 678 | 0.140 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2016 | 474 | 0.130 |
Why?
|
| Seroepidemiologic Studies | 1 | 2016 | 115 | 0.130 |
Why?
|
| Precursor Cells, T-Lymphoid | 1 | 2016 | 1 | 0.130 |
Why?
|
| Histocompatibility, Maternal-Fetal | 1 | 2016 | 2 | 0.130 |
Why?
|
| Peripheral Tolerance | 1 | 2016 | 4 | 0.130 |
Why?
|
| Immunotherapy | 1 | 2021 | 654 | 0.130 |
Why?
|
| Autoimmunity | 1 | 2016 | 172 | 0.120 |
Why?
|
| Gliadin | 1 | 2013 | 5 | 0.110 |
Why?
|
| Transglutaminases | 1 | 2013 | 24 | 0.110 |
Why?
|
| Serologic Tests | 1 | 2013 | 119 | 0.100 |
Why?
|
| GTP-Binding Proteins | 1 | 2013 | 171 | 0.100 |
Why?
|
| Tetraspanins | 1 | 2011 | 30 | 0.100 |
Why?
|
| Lymphopenia | 2 | 2011 | 36 | 0.090 |
Why?
|
| Cell Differentiation | 2 | 2016 | 1915 | 0.090 |
Why?
|
| Acetylation | 2 | 2009 | 166 | 0.090 |
Why?
|
| Antigens, CD | 1 | 2011 | 420 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 2 | 2016 | 370 | 0.080 |
Why?
|
| Receptors, Cell Surface | 1 | 2011 | 469 | 0.080 |
Why?
|
| Antigens, Neoplasm | 1 | 2011 | 390 | 0.080 |
Why?
|
| Interleukin-12 | 1 | 2009 | 114 | 0.080 |
Why?
|
| Interferon Type I | 1 | 2009 | 107 | 0.080 |
Why?
|
| Humans | 8 | 2023 | 122991 | 0.080 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2009 | 121 | 0.080 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2011 | 261 | 0.080 |
Why?
|
| Immunologic Memory | 1 | 2009 | 180 | 0.080 |
Why?
|
| Mice, Transgenic | 3 | 2011 | 2391 | 0.070 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 2006 | 8 | 0.070 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2009 | 396 | 0.070 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2006 | 43 | 0.070 |
Why?
|
| Histones | 2 | 2009 | 528 | 0.070 |
Why?
|
| Jurkat Cells | 1 | 2006 | 76 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2006 | 64 | 0.070 |
Why?
|
| RNA Polymerase II | 1 | 2006 | 99 | 0.070 |
Why?
|
| Serine | 1 | 2006 | 174 | 0.060 |
Why?
|
| Protein Transport | 1 | 2006 | 368 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 1 | 2006 | 1002 | 0.060 |
Why?
|
| Cells, Cultured | 2 | 2006 | 3050 | 0.050 |
Why?
|
| Respiratory Burst | 1 | 2022 | 10 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 2006 | 1335 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2006 | 1610 | 0.050 |
Why?
|
| RNA Splice Sites | 1 | 2022 | 87 | 0.050 |
Why?
|
| Mice | 5 | 2016 | 17468 | 0.050 |
Why?
|
| NADPH Oxidases | 1 | 2022 | 115 | 0.050 |
Why?
|
| Animals | 6 | 2021 | 33692 | 0.050 |
Why?
|
| United States | 1 | 2016 | 10595 | 0.050 |
Why?
|
| Transplantation Immunology | 1 | 2021 | 53 | 0.050 |
Why?
|
| Virtual Reality | 1 | 2021 | 27 | 0.050 |
Why?
|
| Group Processes | 1 | 2021 | 47 | 0.050 |
Why?
|
| Adoptive Transfer | 2 | 2016 | 236 | 0.040 |
Why?
|
| Histocompatibility Testing | 1 | 2021 | 148 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2009 | 2533 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2022 | 481 | 0.040 |
Why?
|
| Motivation | 1 | 2021 | 314 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 252 | 0.040 |
Why?
|
| Female | 3 | 2022 | 65304 | 0.030 |
Why?
|
| Middle Aged | 1 | 2016 | 25929 | 0.030 |
Why?
|
| Genes, T-Cell Receptor alpha | 1 | 2016 | 1 | 0.030 |
Why?
|
| Thymocytes | 1 | 2016 | 7 | 0.030 |
Why?
|
| Self Tolerance | 1 | 2016 | 5 | 0.030 |
Why?
|
| Neuropilin-1 | 1 | 2016 | 15 | 0.030 |
Why?
|
| Arthritis, Experimental | 1 | 2016 | 15 | 0.030 |
Why?
|
| Adult | 1 | 2016 | 28978 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2016 | 312 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2016 | 2306 | 0.030 |
Why?
|
| Inflammation | 1 | 2021 | 1399 | 0.030 |
Why?
|
| Algorithms | 1 | 2021 | 1595 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 815 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2006 | 4507 | 0.030 |
Why?
|
| Male | 2 | 2016 | 59898 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2016 | 804 | 0.030 |
Why?
|
| Pandemics | 1 | 2021 | 1104 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 1294 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2016 | 478 | 0.030 |
Why?
|
| Glucose-6-Phosphate Isomerase | 1 | 2011 | 1 | 0.020 |
Why?
|
| Cytokines | 1 | 2016 | 1280 | 0.020 |
Why?
|
| Antigen Presentation | 1 | 2009 | 106 | 0.020 |
Why?
|
| T-Box Domain Proteins | 1 | 2009 | 122 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2016 | 3710 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2022 | 13819 | 0.020 |
Why?
|
| Pregnancy | 1 | 2016 | 7112 | 0.010 |
Why?
|
| Child | 1 | 2022 | 24144 | 0.010 |
Why?
|